Icahn in biotech buying spree as big pharma prepares to pounce
CATHERINE BOYLE
The Business
08 Sep 2007

CARL ICAHN, the billionaire American financier, is on a biotech buying spree, and has already built investments in five firms in addition to his well-publicised stake in Biogen, the US biotech company. Filings with the US Securities and Exchange... read more...

Tech Tags: The Business newspaper Business News

Eli Lilly, Shanghai firm to develop cancer drugs (The Wall Street Journal Europe, 21 Aug 2007, Page 7)

Eli Lilly, Shanghai firm to develop cancer drugs
By Jane Spencer
The Wall Street Journal Europe
21 Aug 2007

HONG KONG—A drug-development partnership between Eli Lilly & Co. of the U.S. and a Shanghai pharmaceuticals company reflects China’s growing potential as a lowcost center for biotechnology research. Yesterday, Indianapolis-based Lilly announced it... read more...

Tech Tags: The Wall Street Journal Europe newspaper Global Business Briefs

All men over 50 should take drug to lower cholesterol, says heart expert
Polly Curtis Health correspondent
The Guardian
28 Jul 2007

Every man over the age of 50 should be on a daily medication of cholesterol-lowering drugs to protect against heart disease and stroke, the government’s heart tsar said yesterday. Roger Boyle said that blanket prescribing of statins should also apply... read more...

Tech Tags: The Guardian newspaper National

Merck profit jumps 12%
By Peter Loftus —Sara Leitch and Mike Barris contributed to this article.
The Wall Street Journal Europe
24 Jul 2007

Merck & Co. continued its turnaround, posting a 12% increase in second-quarter profit on strong sales of drugs for allergies and cholesterol, as well as vaccines. The improved sales of cholesterol drugs Vytorin and Zetia also helped Merck’s... read more...

Tech Tags: The Wall Street Journal Europe newspaper Corporate News

---

The Constant Populist
By Paul Offit
The Wall Street Journal Europe
13 Jul 2007

In Michael Moore’s “Sicko,” pharmaceutical companies are taken to the movies. It isn’t the first time. In “The Constant Gardener,” a pharmaceutical company that also does pesticides makes an antibiotic that is highly effective against... read more...

Tech Tags: The Wall Street Journal Europe newspaper Editorials & Opinion

Sanofi pulls request to sell obesity drug in the U.S.
By Jeanne Whalen
The Wall Street Journal Europe
02 Jul 2007

Sanofi-Aventis said it is withdrawing its application to sell the obesity drug rimonabant in the U.S. but plans to resubmit it at a future date, admitting the defeat, for now, of what it hoped would be a blockbuster medicine. The move comes two weeks... read more...

Tech Tags: The Wall Street Journal Europe newspaper Corporate News

With Paris suit, Abbott riles AIDS activists on a new front
By John Carreyrou And Avery Johnson
The Wall Street Journal Europe
18 Jun 2007

BREAKING WHAT has become a taboo in the pharmaceutical industry’s respectful relations with AIDS activists, Abbott Laboratories has sued a French AIDS group for launching a cyber attack against its Web site. The unusually aggressive legal move comes... read more...

Tech Tags: The Wall Street Journal Europe newspaper Marketplace